Navigation Links
China-Biotics, Inc. to Present at Two Upcoming Investor Conferences

SHANGHAI, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced the Company's management will present at two upcoming investor conferences: Brean Murray, Carret & Co.'s The All-Cap All-China Conference in New York City and the ROTH China Discovery Tour in Sanya, China.

The date, time and location of China-Biotics' presentations at these conferences are:

Brean Murray, Carret & Co.'s The All-Cap All-China Conference

Date: Monday, May 19, 2008

Time: 2:45 p.m. EDT

Venue: Jade Room

The Waldorf=Astoria

New York, NY

The conference will feature formal group presentations and one-on-one meetings with approximately 100 Chinese companies. The participating companies will span the market cap spectrum from large-cap companies to private, "soon-to-be-listed" companies. Interested parties and institutional investors may register for the conference by visiting the conference Web site at: 325.

The presentation will also be webcast live over the Internet and can be accessed by all interested parties at or the Company's Web site, .

ROTH China Discovery Tour 2008

Date: Friday, May 23, 2008

Time: 2:40 a.m. EDT

Venue: Chi Gu 2

Ritz-Carlton Hotel

Sanya, China

The 3rd Annual ROTH China Discovery Tour will feature more than 70 companies in seven cities throughout China, combining factory visits with management presentations in a mini-conference format. During the past two years, ROTH has taken investors on more than 60 company visits in mainland China and hosted close to 200 Chinese company presentations at its conferences. For more information about this invitation-only event, please contact

About China-Biotics, Inc.

Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the Company") was founded in 1999 and is one of China's largest suppliers of probiotics. Probiotics are beneficial live bacteria used as dietary supplements and food additives to improve intestinal health and digestion. The Company's product portfolio contains live microbials made with proprietary technology. Currently, these products are sold over-the-counter under the "Shining" brand through large distributors to more than 1,000 pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the most recognized brands in Shanghai. China-Biotics plans to expand its retail sales to other major cities in China and will launch 300 Shining brand logistic centers in these cities during the next two years. The Company's flagship product, "Shining Essence", has been a profit driver since its launch in April 2001. There is a significant demand for probiotics for use in the bulk additive market, which is currently met by imports. China-Biotics is building a new plant which will increase its production capacity manifolds to capture this market. For more information, please visit .

For more information, please contact:

CCG Elite Investor Relations

Crocker Coulson, President

Tel: +1-646-213-1915 (New York)



SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Completes Foundation for Its New Plant
2. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
3. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
4. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
5. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
6. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
7. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
8. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
9. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
10. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
(Date:6/21/2016)... June 21, 2016 NuData Security announced today ... role of principal product architect and that ... of customer development. Both will report directly to ... The moves reflect NuData,s strategic growth in its ... high customer demand and customer focus values. ...
(Date:6/16/2016)... SAN FRANCISCO , June 16, 2016 /PRNewswire/ ... Market size is expected to reach USD ... report by Grand View Research, Inc. Technological proliferation ... and banking applications are expected to drive the ... ) , The development of ...
Breaking Biology News(10 mins):